Development of resistance to ciprofloxacin, rifampin, and mupirocin in methicillin-susceptible and -resistant Staphylococcus aureus isolates

被引:40
作者
Schmitz, FJ
Fluit, AC
Hafner, D
Beeck, A
Perdikouli, M
Boos, M
Scheuring, S
Verhoef, J
Köhrer, K
Von Eiff, C
机构
[1] Univ Dusseldorf, Inst Med Microbiol & Virol, D-40225 Dusseldorf, Germany
[2] Univ Dusseldorf, Inst Pharmacol & Clin Pharmacol, D-40225 Dusseldorf, Germany
[3] Univ Munster, Inst Med Microbiol, D-4400 Munster, Germany
[4] Univ Utrecht, Med Ctr, Eljkman Winkler Inst Med Microbiol, Utrecht, Netherlands
关键词
D O I
10.1128/AAC.44.11.3229-3231.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A relationship between resistance to methicillin and resistance to fluoroquinolones, rifampin, and mupirocin has been described for Staphylococcus aureus. Differences in resistance rates may be explainable by a higher spontaneous mutation rate (MR) or a faster development of resistance (DIFF) in methicillin-resistant S. aureus (MRSA). No differences in MR, DIFF, and mutations in grlA. and gyrA were detected between methicillin-susceptible S. aureus and MRSA. The higher resistance rates in MRSA are not the result of hypermutability of target genes or a faster emergence of different mutations and may be the consequence of clonal spread of multiresistant MRSA.
引用
收藏
页码:3229 / 3231
页数:3
相关论文
共 14 条
  • [1] Characterization of mutations in the rpoB gene that confer rifampin resistance in Staphylococcus aureus
    Aubry-Damon, H
    Soussy, CJ
    Courvalin, P
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) : 2590 - 2594
  • [2] BERGERBACHI B, 1983, J BACTERIOL, V154, P479
  • [3] The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice
    Cookson, BD
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (01) : 11 - 18
  • [4] ANALYSIS OF GYRA AND GRLA MUTATIONS IN STEPWISE-SELECTED CIPROFLOXACIN-RESISTANT MUTANTS OF STAPHYLOCOCCUS-AUREUS
    FERRERO, L
    CAMERON, B
    CROUZET, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (07) : 1554 - 1558
  • [5] Mechanisms of fluoroquinolone resistance
    Hooper, DC
    [J]. DRUG RESISTANCE UPDATES, 1999, 2 (01) : 38 - 55
  • [6] High mutation frequencies among Escherichia coli and Salmonella pathogens
    LeClerc, JE
    Li, BG
    Payne, WL
    Cebula, TA
    [J]. SCIENCE, 1996, 274 (5290) : 1208 - 1211
  • [7] *NAT COMM CLIN LAB, 1997, METH DIL ANT TESTS B
  • [8] High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection
    Oliver, A
    Cantón, R
    Campo, P
    Baquero, F
    Blázquez, J
    [J]. SCIENCE, 2000, 288 (5469) : 1251 - 1253
  • [9] Schmitz FJ, 1999, FEMS IMMUNOL MED MIC, V26, P281, DOI 10.1111/j.1574-695X.1999.tb01400.x
  • [10] The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals
    Schmitz, FJ
    Lindenlauf, E
    Hofmann, B
    Fluit, AC
    Verhoef, J
    Heinz, HP
    Jones, ME
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (04) : 489 - 495